U.K. Tightens Restrictions On Nonprescription Pain Reliever Sales
This article was originally published in The Tan Sheet
The U.K. Medicines and Healthcare products Regulatory Agency recommends retailers restrict sales of nonprescription pain relievers to two packs per transaction to reduce the risk of overdose - a strategy an FDA working group rejected
You may also be interested in...
A joint advisory committee recommended as a "top priority" that FDA lower the maximum single and daily dose of acetaminophen, despite inconclusive data that the current dose poses significant hepatotoxicity risks
Acetaminophen product manufacturers stand to incur huge costs and reduced revenue opportunities if FDA implements a working group's recommendations to reduce hepatotoxicity risk
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC